Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0010200 (
cough
)
23,843
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
At the end of her menstruation a 25 years old woman develops acute pain in her right lower and upper abdomen radiating into the right shoulder. There are pains during breathing,
coughing
, and changing of position, vomitus, and local signs of peritonitis in the right lower and upper abdomen, subicterus and leucocytosis. Gonococci in the cervical smear are demonstrated by Grams stain and by culture. Two days after treatment with 3,5 millions IU of penicillin G sodium and 500.000 IU procaine penicillin per day the complaints disappeared. The demonstrated signs and symptoms are characteristic for acute
perihepatitis
gonorrhoica which seems to occur more often as a complication of gonococcal adnexitis than is suspected. The symptoms are so typical that the diagnosis can be made also without confirmation by laparascopy.
...
PMID:[Clinical diagnosis of acute gonorrhic perihepatitis]. 65 2
The Hitchner B-1 strain of Newcastle disease virus was plaque-cloned and then serially passaged 36 times in specific-pathogen-free (SPF) chicken embryos incubated at two different temperatures. Virus passaged at a reduced temperature (29 C) was identified as cold-adapted (Ca) and virus passaged at the normal temperature (37 C) was designated non-cold-adapted (non-Ca). The Ca and non-Ca B-1 viruses were compared with the parent B-1 and a commercial B-1 vaccine. In vitro Ca B-1 characteristics included adaptation for more rapid growth at 29 C and the aquisition of temperature sensitivity indicated by substantially reduced growth at 41 C, properties not seen with non-Ca B-1. Embryo mean death times for the Ca virus (140 hr) were longer than for non-Ca B-1 (107 hr) and parent B-1 (121 hr) viruses. The Ca virus retained a rapid (< 2 hr) hemagglutination (HA) elution rate but lost the property of binding the monoclonal antibody AVS-I typical of other B-1 strains. The pathogenicity of the Ca B-1 strain was compared to the non-Ca B-1, parent B-1 strain, and a commercial B-1 strain vaccine in 1-day-old broiler-type chickens. Pathogenicity was evaluated by assessing the severity of respiratory disease signs and the incidence of airsacculitis,
perihepatitis
, and pericarditis lesions in inoculated chicks. A respiratory disease index was calculated for each B-1 strain based on daily observation scores that determined the presence or absence of disease signs (
coughing
, rales, labored breathing, death) from 1 to 14 days following intratracheal inoculation with 10(6) 50% egg infective doses of virus per chick. The lower respiratory disease index obtained for the Ca B-1 strain (0.075) indicated it was less pathogenic than the commercial B-1 vaccine (0.296) and the non-Ca (0.478) and parent (0.521) B-1 strains. Ca B-1-infected chicks had only a 5% incidence of air sac lesions, compared to chicks given non-Ca (65%), Hitchner B-1 (65%), or a commercial B-1 vaccine (30%). Immunogenicity tests performed in 1-week-old SPF leghorn chickens demonstrated that Ca B-1 induced complete protection when administered intraocularly as a single entity. However, when Ca B-1 was given in combination with a modified live infectious bronchitis virus vaccine, chickens were only partially protected (60-75%) against Texas GB strain-induced neurotropic velogenic Newcastle disease.
...
PMID:Attenuation of lentogenic Newcastle disease virus strain B-1 by cold adaptation. 888 91